health pharma news today obesity drugs glp-1 today A new oral option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related FDA Approves Eli Lilly's Obesity

This study found an average of 4 mcg/d vitamin D, compared to the national average of 19 mcg/d from food and supplements, highlighting the significant need for Vitamin D-rich foods and supplementation for this population (44)

Epstein, declare competing financial interests as they are employees and consultants of NovoBiotic Pharmaceuticals

Administered via intramuscular injection, it ensures sustained energy levels and improved work output

Why is there so much more research available on GHK-Cu compared to KLOW

Among those who tolerate and stay on GLP 1 therapy, observational studies show consistent improvements in weight related quality of life, physical functioning, and emotional health over 612 months

A brighter, more even-toned complexion with reduced dark spots and hyperpigmentation